The Schottky interface modulates and/or amplifies the electrical signal by the directional transfer of endogenous electrons around the Schottky interface [31], thereby augmenting Bmal1 expression and enhancing the antioxidant response mediated by the Bmal1-Nrf2 axis for AT treatment. The gene discussed is NFE2L2; the disease is ataxia telangiectasia.